News
Konkret gehe es in den Gesprächen um das Lungenkrebsmedikament Ivonescimab von Summit, so die Agentur weiter. Über die ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback